Fortell AI Hearing Aids vs Lexie B3

The Fortell AI Hearing Aids are a premium prescription behind-the-ear device priced at $6,800, earning an A grade with a SoundScore of 6.0/5 in HearAdvisor lab testing—an exceptional result that places this device at the top of the prescription hearing aid category. Speech performance is where the Fortell AI truly distinguishes itself. Speech in noise scores an outstanding 6.0/5, a full 3.89 points above the category average of 2.11/5—the kind of margin that represents a meaningful difference in challenging listening environments like restaurants or group conversations. Speech in quiet also excels at 4.6/5, sitting 1.20 points above the category average. Music streaming performs strongly at 4.2/5, coming in 1.44 points above average for the category. The device does have a notable limitation: own-voice comfort scores just 1.5/5, falling 1.20 points below the category average. This low absolute score suggests wearers may notice occlusion effects when speaking. Feedback handling is excellent at 4.8/5, essentially matching the category average. Best suited for: Users who prioritize understanding speech in difficult listening situations and value streaming quality, and who can tolerate potential own-voice occlusion. Given the premium price point, buyers should weigh whether the exceptional speech-in-noise performance justifies the investment compared to alternatives like the Oticon Intent or Oticon Zeal, which offer strong performance at lower price points.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.